In Vivo Efficacy CROs for Rhesus monkey Studies

5 contract research organizations in our directory list both In Vivo Efficacy and Rhesus monkey among their capabilities, based in US. 3 report GLP capability and 4 report AAALAC accreditation. Confirm species-specific experience with each lab when you get in touch.

5 CROs 3 GLP 4 AAALAC 1 country

Showing 5 CROs. Order rotates daily so no lab is permanently listed first.

Tulane National Primate Research Center

US GLP AAALAC

National primate research center with high-containment capability supporting infectious disease, vaccine and translational NHP studies, including sponsored research.

In Vivo Efficacy Infectious Disease Models Vaccine Development Rhesus monkey Non-human Primate

Biomere

US Verified AAALAC

Biomere (a JOINN company) is a preclinical CRO based in Worcester, MA. Services include non-GLP PK/PD, discovery toxicology, surgical services, disease models, and laboratory sciences. Surgical services include…

In Vivo Efficacy AAV Biodistribution Bioanalysis Bioavailability Studies Biodistribution Rhesus monkey Cynomolgus monkey Minipig Mouse

Texas Biomedical Research Institute

US GLP

Independent nonprofit research institute with a national primate research center and high-containment labs, offering contract infectious disease, vaccine and NHP studies.

In Vivo Efficacy Infectious Disease Models Toxicology Vaccine Development Rhesus monkey Cynomolgus monkey Mouse Non-human Primate

Oregon National Primate Research Center

US AAALAC

OHSU national primate research center supporting neuroscience, metabolic, reproductive and infectious disease research, with core services available to outside investigators.

In Vivo Efficacy CNS Disease Models Infectious Disease Models Metabolic Disease Models Rhesus monkey Non-human Primate

Alpha Genesis

US GLP AAALAC

Vertically integrated nonhuman primate CRO in South Carolina combining on-site breeding with discovery pharmacology, GLP toxicology, vaccine and gene therapy studies.

In Vivo Efficacy Gene Therapy Studies GLP Toxicology Pharmacokinetics Vaccine Development Rhesus monkey Cynomolgus monkey Mouse Non-human Primate

Questions to ask when choosing an In Vivo Efficacy in Rhesus monkey CRO

  • What positive-control data do you have for this model from the past 12 months, and what is the typical effect size and variability?
  • How are animals randomized, and is scoring blind to treatment?
  • How did you choose group size for the primary endpoint?
  • Can PK and biomarker samples be taken from the efficacy animals?
  • How quickly will we see interim data, and in what format?